Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

1.

Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice daily.

Yuen GJ, Lou Y, Bumgarner NF, Bishop JP, Smith GA, Otto VR, Hoelscher DD.

Antimicrob Agents Chemother. 2004 Jan;48(1):176-82.

PMID:
14693537
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjects.

Moyle G, Boffito M, Fletcher C, Higgs C, Hay PE, Song IH, Lou Y, Yuen GJ, Min SS, Guerini EM.

Antimicrob Agents Chemother. 2009 Apr;53(4):1532-8. doi: 10.1128/AAC.01000-08. Epub 2009 Feb 2.

PMID:
19188387
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Pharmacokinetics of lamivudine and lamivudine-triphosphate after administration of 300 milligrams and 150 milligrams once daily to healthy volunteers: results of the ENCORE 2 study.

Else LJ, Jackson A, Puls R, Hill A, Fahey P, Lin E, Amara A, Siccardi M, Watson V, Tjia J, Emery S, Khoo S, Back DJ, Boffito M.

Antimicrob Agents Chemother. 2012 Mar;56(3):1427-33. doi: 10.1128/AAC.05599-11. Epub 2011 Dec 19.

PMID:
22183172
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1.

Moore KH, Barrett JE, Shaw S, Pakes GE, Churchus R, Kapoor A, Lloyd J, Barry MG, Back D.

AIDS. 1999 Nov 12;13(16):2239-50.

PMID:
10563709
[PubMed - indexed for MEDLINE]
5.

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.

Musiime V, Kendall L, Bakeera-Kitaka S, Snowden WB, Odongo F, Thomason M, Musoke P, Adkison K, Burger D, Mugyenyi P, Kekitiinwa A, Gibb DM, Walker AS; ARROW Trial team.

Antivir Ther. 2010;15(8):1115-24. doi: 10.3851/IMP1695.

PMID:
21149918
[PubMed - indexed for MEDLINE]
6.

Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV.

Bruno R, Regazzi MB, Ciappina V, Villani P, Sacchi P, Montagna M, Panebianco R, Filice G.

Clin Pharmacokinet. 2001;40(9):695-700.

PMID:
11605717
[PubMed - indexed for MEDLINE]
7.

Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.

Flynn PM, Rodman J, Lindsey JC, Robbins B, Capparelli E, Knapp KM, Rodriguez JF, McNamara J, Serchuck L, Heckman B, Martinez J; PACTG P1012 Team.

Antimicrob Agents Chemother. 2007 Oct;51(10):3516-22. Epub 2007 Jul 30.

PMID:
17664328
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Abacavir/lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with each component administered concurrently and the effect of food on absorption.

Yuen GJ, Lou Y, Thompson NF, Otto VR, Allsup TL, Mahony WB, Hutman HW.

J Clin Pharmacol. 2001 Mar;41(3):277-88.

PMID:
11269568
[PubMed - indexed for MEDLINE]
9.

Plasma amprenavir pharmacokinetics and tolerability following administration of 1,400 milligrams of fosamprenavir once daily in combination with either 100 or 200 milligrams of ritonavir in healthy volunteers.

Ruane PJ, Luber AD, Wire MB, Lou Y, Shelton MJ, Lancaster CT, Pappa KA; COL10053 Study Team.

Antimicrob Agents Chemother. 2007 Feb;51(2):560-5. Epub 2006 Nov 6.

PMID:
17088488
[PubMed - indexed for MEDLINE]
Free PMC Article
10.
11.

The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals.

van Heeswijk RP, Veldkamp AI, Mulder JW, Meenhorst PL, Wit FW, Lange JM, Danner SA, Foudraine NA, Kwakkelstein MO, Reiss P, Beijnen JH, Hoetelmans RM.

AIDS. 2000 May 26;14(8):F77-82.

PMID:
10853971
[PubMed - indexed for MEDLINE]
12.

A review of the pharmacokinetics of abacavir.

Yuen GJ, Weller S, Pakes GE.

Clin Pharmacokinet. 2008;47(6):351-71. Review.

PMID:
18479171
[PubMed - indexed for MEDLINE]
13.
14.

A single-dose, randomized, open-label, two-period crossover bioequivalence study comparing a fixed-dose pediatric combination of lamivudine and stavudine tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.

Monif T, Reyar S, Tiwari HK, Tippabhotla SK, Khuroo A, Thudi NR, Ahmed S, Raghuvanshi R.

Arzneimittelforschung. 2009;59(2):104-8. doi: 10.1055/s-0031-1296371.

PMID:
19338141
[PubMed - indexed for MEDLINE]
15.

Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months.

Paediatric European Network for Treatment of AIDS (PENTA).

Antivir Ther. 2010;15(3):297-305. doi: 10.3851/IMP1532.

PMID:
20516550
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with lamivudine and zidovudine administered concurrently and the effect of food on absorption.

Moore KH, Shaw S, Laurent AL, Lloyd P, Duncan B, Morris DM, O'Mara MJ, Pakes GE.

J Clin Pharmacol. 1999 Jun;39(6):593-605.

PMID:
10354963
[PubMed - indexed for MEDLINE]
17.

Pharmacokinetics of nevirapine: once-daily versus twice-daily dosing in the 2NN study.

Kappelhoff BS, Huitema AD, van Leth F, Robinson PA, MacGregor TR, Lange JM, Beijnen JH; 2NN Study Group.

HIV Clin Trials. 2005 Sep-Oct;6(5):254-61.

PMID:
16306032
[PubMed - indexed for MEDLINE]
Free Article
18.

Steady-state pharmacokinetics of once-daily cyclobenzaprine extended release: a randomized, double-blind, 2-period crossover study in healthy volunteers.

Darwish M, Hellriegel ET.

Clin Ther. 2011 Jun;33(6):746-53. doi: 10.1016/j.clinthera.2011.05.045.

PMID:
21704239
[PubMed - indexed for MEDLINE]
19.

Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults.

Byakika-Tusiime J, Chinn LW, Oyugi JH, Obua C, Bangsberg DR, Kroetz DL.

PLoS One. 2008;3(12):e3981. doi: 10.1371/journal.pone.0003981. Epub 2008 Dec 19.

PMID:
19096711
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults.

Hosseinipour MC, Corbett AH, Kanyama C, Mshali I, Phakati S, Rezk NL, van der Horst C, Kashuba AD.

AIDS. 2007 Jan 2;21(1):59-64.

PMID:
17148968
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk